Literature DB >> 3130926

Raised plasma intact parathyroid hormone concentrations in young people with mildly raised blood pressure.

D E Grobbee1, W H Hackeng, J C Birkenhäger, A Hofman.   

Abstract

To study the role of parathyroid gland activity in early primary hypertension plasma concentrations of intact parathyroid hormone were measured in 90 untreated young subjects, aged 16-29, with stable midly raised blood pressure and in 40 normotensive control subjects selected from the same population in Zoetermeer, The Netherlands. Intact parathyroid hormone concentration was significantly higher in the hypertensive than the normotensive group (2.34 (SE 0.11) pmol/l v 1.47 (0.13) pmol/l, respectively; difference 0.87 pmol/l; 95% confidence interval 0.55 to 1.21; p less than 0.0001). Serum total calcium concentration was 2.36 (0.01) mmol/l in the hypertensive group and 2.42 (0.01) mmol/l in the normotensive group (difference 0.06 mmol/l; 95% confidence interval 0.02 to 0.09; p = 0.02). Urinary calcium excretion over 24 hours did not differ significantly between the two groups (4.17 (0.28) mmol/24 h in the hypertensive group and 3.89 (0.39) mmol/24 h in the normotensive group; difference 0.28 mmol/24 h; 95% confidence interval -0.66 to 1.22). In the hypertensive group both systolic and diastolic blood pressures increased slightly though significantly with intact parathyroid hormone concentrations. No obvious associations between serum calcium concentration and blood pressure were observed. These findings support the view that enhanced activity of the parathyroid gland may play a part in the early stage of primary hypertension.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3130926      PMCID: PMC2545104          DOI: 10.1136/bmj.296.6625.814

Source DB:  PubMed          Journal:  Br Med J (Clin Res Ed)        ISSN: 0267-0623


  25 in total

1.  Hypertension in hyperparathyroidism.

Authors:  J HELLSTROM; G BIRKE; C A EDVALL
Journal:  Br J Urol       Date:  1958-03

2.  Correlation of platelet calcium with blood pressure. Effect of antihypertensive therapy.

Authors:  P Erne; P Bolli; E Bürgisser; F R Bühler
Journal:  N Engl J Med       Date:  1984-04-26       Impact factor: 91.245

3.  Calcium and blood pressure.

Authors:  G M Palmieri; T E Bertorini; D F Nutting
Journal:  Lancet       Date:  1986-11-08       Impact factor: 79.321

Review 4.  The calcium deficiency hypothesis of hypertension: a critique.

Authors:  N M Kaplan; R B Meese
Journal:  Ann Intern Med       Date:  1986-12       Impact factor: 25.391

5.  Alterations of dietary calcium intake as a therapeutic modality in essential hypertension.

Authors:  L M Resnick
Journal:  Can J Physiol Pharmacol       Date:  1986-06       Impact factor: 2.273

6.  Effect of parathyroid hormone on osmotic fragility of human erythrocytes.

Authors:  E Bogin; S G Massry; J Levi; M Djaldeti; G Bristol; J Smith
Journal:  J Clin Invest       Date:  1982-04       Impact factor: 14.808

7.  Serum calcium fractions in essential hypertensive and matched normotensive subjects.

Authors:  A R Folsom; C L Smith; R J Prineas; R H Grimm
Journal:  Hypertension       Date:  1986-01       Impact factor: 10.190

8.  Enhanced parathyroid function in essential hypertension: a homeostatic response to a urinary calcium leak.

Authors:  D A McCarron; P A Pingree; R J Rubin; S M Gaucher; M Molitch; S Krutzik
Journal:  Hypertension       Date:  1980 Mar-Apr       Impact factor: 10.190

9.  Parathyroids, thyroid and development of hypertension in SHR.

Authors:  R Schleiffer; A Berthelot; F Pernot; A Gairard
Journal:  Jpn Circ J       Date:  1981-11

10.  Abnormalities of calcium metabolism in essential hypertension.

Authors:  P Strazzullo; V Nunziata; M Cirillo; R Giannattasio; L A Ferrara; P L Mattioli; M Mancini
Journal:  Clin Sci (Lond)       Date:  1983-08       Impact factor: 6.124

View more
  6 in total

Review 1.  The association between metabolic syndrome and bone mineral density: a meta-analysis.

Authors:  Peng Xue; Ping Gao; Yukun Li
Journal:  Endocrine       Date:  2012-05-01       Impact factor: 3.633

Review 2.  The role of calcium supplementation in the treatment of hypertension. Current evidence.

Authors:  D E Grobbee; H J Waal-Manning
Journal:  Drugs       Date:  1990-01       Impact factor: 9.546

Review 3.  The Impact of Antihypertensive Medications on Bone Mineral Density and Fracture Risk.

Authors:  Joshua I Barzilay; Barry R Davis; Sara L Pressel; Alokananda Ghosh; Rachel Puttnam; Karen L Margolis; Paul K Whelton
Journal:  Curr Cardiol Rep       Date:  2017-09       Impact factor: 2.931

4.  Association between metabolic syndrome and bone mineral density in a Taiwanese elderly population.

Authors:  Song-Seng Loke; Hsueh-Wen Chang; Wen-Cheng Li
Journal:  J Bone Miner Metab       Date:  2017-03-16       Impact factor: 2.626

5.  Parathyroid hormone and arterial dysfunction in the multi-ethnic study of atherosclerosis.

Authors:  Cortney Bosworth; Michael C Sachs; Daniel Duprez; Andrew N Hoofnagle; Joachim H Ix; David R Jacobs; Carmen A Peralta; David S Siscovick; Bryan Kestenbaum; Ian H de Boer
Journal:  Clin Endocrinol (Oxf)       Date:  2013-05-20       Impact factor: 3.478

6.  The association between bone health indicated by calcaneal quantitative ultrasound and metabolic syndrome in Malaysian men.

Authors:  Kok-Yong Chin; Soelaiman Ima-Nirwana; Isa Naina Mohamed; Fairus Ahmad; Elvy Suhana Mohd Ramli; Amilia Aminuddin; Wan Zurinah Wan Ngah
Journal:  J Diabetes Metab Disord       Date:  2015-03-07
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.